Joining the #20kmbxl ? 🏃

Make sure to stop by the #MissionCancer stand!

My awesome team will be there to share with you how the Mission aims to improve peoples' lives through prevention, cure and for those affected by cancer to live longer & better.

🔗 europa.eu/!HFxt38

The OncoAlert 🚨Network Warmly extends its congratulations to Two of our Distinguished Faculty, part of our Founding faculty and ESMO - Eur. Oncology Presidents:

⚕️ Solange Peters 🇨🇭 from CHUV / Centre hospitalier universitaire vaudois
⚕️ FabriceAndre 🇫🇷 from Gustave Roussy

Named Giants of Cancer Care, an award that…

My mother is eighty years old…she still dedicates a lot of her time to charity work.
Her endurance is a bit scary…

Big news for European #cancer #patients 🇪🇺

Selpercatinib has been approved by EU Medicines Agency for advanced RET fusion positive solid tumours 🎯

This marks the 2nd tumour agnostic, biomarker-driven approval in the EU.

#PrecisionMedicine OncoAlert 🚨

ec.europa.eu/health/documen…

Completely agree with our OncoAlert 🚨Faculty Ben Westphalen 🇩🇪

We have been seeing the same with the emergence of new accounts that are NOT adding to the conversation but rather are the same echo chambers we have been avoiding in Oncology SoMe

OncoAlert has always been and…

📌Today - Connect with the experts and have your questions answered during the live Q&A for this #ESMOGuidelines webinar. Register with your ESMO account: Christina Ruhlmann Pablo Mando Alice Indini

🔗ow.ly/F2mc50Rg9gp

I’ve been on Twitter for 15 years…

A couple of years ago I rediscovered Twitter & what benefits it could have in the professional setting…

Today, I find myself unable to navigate the platform properly & see relevant content watered down (even with filtering, lists etc) 😵‍💫

Ben Westphalen JCO Precision Oncology OncoAlert Ben Westphalen Absolutely, the inclusion of ethnic diversity in #CancerResearch is crucial for truly effective #PrecisionMedicine . Ensuring varied genetic backgrounds can help tailor more accurate treatment protocols. For those interested in a deeper dive, sciqst.com…

What a powerhouse 🤩🤩

Dear Colleagues,
One Month until #ASCO24 🌐
WE ARE READY
WE ARE OncoAlert 🚨

#OncoAlertAF
Dra. María Natalia Gandur Quiroga 🇦🇷
Alizée Camps - - Maléa 🇫🇷
Marta Perachino 🇮🇹
Kathrin Heinrich 🇩🇪
Biagio Ricciuti, MD PhD 🇺🇸
Deniz Can Guven 🇹🇷
Emre Yekedüz 🇺🇸
Hidehito HORINOUCHI 🇯🇵
Fadi Haddad, MD 🇺🇸
Dr. Iván R. González 🇲🇽…

#Cancer #Genomics play an integral part in our understanding of of malignant diseases. Yet, #ethnic #diversity in #Cancer Research is lacking behind.

Important manuscript in JCO Precision Oncology highlighting this critical issue.

#PrecisionMedicine OncoAlert 🚨
ascopubs.org/doi/10.1200/PO…

First ESMO - Eur. Oncology Virtual Journal Club on May 22 at 630pm (CEST) - pencil down your agendas! Important data to be discussed by experts George Pentheroudakis FabriceAndre Solange Peters Andres Cervantes
esmo.org/about-esmo-mee…

#OpenAccess #ResearchPaper in npj Journals #PrecisionOncology 👇🏼

Data from 3499 #PancreaticCancer samples shows distinct molecular & immune profiles in head vs. body/tail #cancers

#pancsm 💜 OncoAlert 🚨 Aatur Singhi, MD PhD KenOliveLab

nature.com/articles/s4169…

This is important👇🏼
The #EUMissions provide extensive funding to help addressing the most pressing problems of our time!

🚨Just in 👉🏼FDA grants accelerated approval to tovorafenib for patients with relapsed or refractory BRAF-altered pediatric low-grade glioma
✅First targeted therapy approved for BRAF fusions. #PrecisionMedicine for the win🎯🧬OncoDaily OncoAlert OncLive.com
Link to approval.…

Phase I TROPION-PanTumor01 Study

✅Dato-DXd💊Shows promising efficacy and manageable safety in heavily pretreated🧬 HR+/HER2– #BreastCancer and #TNBC patients

➡️suggesting potential for advancement to phase III studies‼️

Aditya Bardia, MD
Ian E. Krop Dana-Farber…

Thank you Heather Hampel for your positive opinion on our paper and for recommending it. We really hope it can be of benefit for many colleagues
CA: A Cancer Journal for Clinicians
Ben Westphalen Umberto Malapelle Vivek Subbiah, MD Clare Turnbull- Prof/NHS Dr Debyani Chakravarty, PhD 🇺🇦 Nicola Normanno Melissa B Davis, PhD

⭐️Fantastic overview of #MolecularTumorBoards -MTB 101 & in depth thought provoking lecture - by the amazing Ben Westphalen at the Italian summit for precision 💊 medicine!
What are MTB’s? Panel of multi-D expert who review molecular-profiling results & match to available…

The 2020 paper by Fernanda Mosele & FabriceAndre on the use of NGS in advanced #Cancer is a landmark in #PrecisionMedicine ⭐️

Now there is an update in press in Annals of Oncology & we get a sneak peek during todays 🇮🇹 #precisionmedicine summit 🤩

#PrecisionMedicine OncoAlert 🚨

The OncoAlert🚨ROUND UP is OUT
Covering April 12-18, 2024

REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

Covering:
✅Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma out on NEJM
nejm.org/doi/full/10.10…

✅Timing of Radiotherapy (RT) After…